Aspergillus Fumigatus (Asp f 6) IgE Test · Blood

If you have asthma or cystic fibrosis and your breathing is harder than it should be, a fungus called Aspergillus fumigatus may be quietly making things worse. This test looks for an antibody (IgE) your immune system has made against one specific protein from that mold, called Asp f 6. The result helps separate two very different situations: a harmless allergic reaction to mold in the air, or a more serious lung condition called ABPA (allergic bronchopulmonary aspergillosis) that can scar your airways.

Routine allergy panels and basic Aspergillus tests often flag mold sensitivity but cannot tell you which kind you have. Asp f 6 IgE is one of the most specific signals available for ABPA. It is an advanced test, used by lung and allergy specialists in people who already have respiratory symptoms, not a general screen for healthy adults.

What This Antibody Actually Reflects

Asp f 6 (the formal name is manganese superoxide dismutase) is a protein found inside Aspergillus fumigatus cells. When your immune system encounters it and decides to treat it as a threat, it produces IgE, the antibody class behind allergic reactions. The IgE level in your blood reflects how strongly your body has mounted a type-2 allergic response (the same kind of immune response behind hay fever and asthma) against this particular fungal protein.

A positive result means your immune system has been primed to react to Asp f 6. A high result, especially combined with high total IgE and reactivity to a sister protein called Asp f 4, points toward ABPA rather than a casual mold allergy. In one Chinese study, 66.7% of ABPA patients were Asp f 6 positive compared with only 14.8% of asthmatics who were merely sensitized to Aspergillus.

Why It Matters for ABPA

ABPA is the most important condition this antibody helps detect. It happens when Aspergillus colonizes the airways in some people with asthma or cystic fibrosis and triggers a damaging allergic response that, untreated, can lead to bronchiectasis (permanently widened, scarred airways) and fixed loss of lung function.

Studies in cystic fibrosis have shown that people with ABPA have specific IgE to Asp f 4 and Asp f 6 at levels roughly 16 to 18 times higher than cystic fibrosis patients without ABPA. In asthmatic adults, skin reactions to Asp f 6 occur almost exclusively in those with ABPA, not in people who are simply Aspergillus-sensitized. That makes Asp f 6 one of the strongest tools for separating the two.

A meta-analysis of recombinant Aspergillus allergens found that IgE to Asp f 4 or Asp f 6 had a pooled specificity of 99.2% for ABPA in asthma, meaning a positive result almost always points to genuine ABPA rather than background mold sensitivity. In cystic fibrosis, the specificity was 93.9%. The trade-off is sensitivity: not everyone with ABPA tests positive, so a negative Asp f 6 does not rule the disease out.

Why a Single Reading Can Mislead

Asp f 6 is what allergists call a pan-fungal allergen. The same protein family exists in many molds and yeasts, so cross-reactivity can produce a positive result even when Aspergillus is not the real driver. People with atopic dermatitis (eczema) often have elevated Asp f 6 IgE because of broad fungal cross-sensitization, and this can blur the picture if you are being evaluated for ABPA.

Guidelines explicitly note that Asp f 6 IgE is helpful but not specific on its own, and that false positives are common in patients with eczema. The result is most useful when interpreted alongside whole-extract Aspergillus IgE, total IgE, Aspergillus-specific IgG, blood eosinophil count, and chest imaging.

Lung Function and Exacerbation Risk

Aspergillus fumigatus sensitization in asthma is associated with measurably lower lung function and a higher risk of fixed airway obstruction. In a study of 149 ABPA patients, those with initial Aspergillus-specific IgE above 9.88 kUA/L had a higher one-year risk of exacerbation. While that study used whole-extract IgE rather than Asp f 6 specifically, it shows that higher antibody levels generally track with worse disease activity in this population.

Tracking Your Trend

Component IgE results like Asp f 6 are most useful as a one-time diagnostic snapshot rather than a routine monitoring tool. Studies in ABPA show that total IgE typically falls by around 50% within weeks of starting steroids and rises again by 50% or more during a flare, while Aspergillus-specific component IgE moves much less and can even tick up slightly during treatment.

If you and your specialist suspect ABPA, get a baseline Asp f 6 IgE alongside total IgE, whole-extract Aspergillus IgE, Aspergillus IgG, and an eosinophil count. Repeat total IgE every 6 to 8 weeks if you are being treated, and every 6 to 12 months if you are stable. Component tests like Asp f 6 generally only need to be redrawn if your diagnosis is being reconsidered or your clinical picture changes substantially.

What an Out-of-Pattern Result Should Prompt

A positive Asp f 6 IgE in someone with asthma, cystic fibrosis, or unexplained airway disease is a flag to take seriously. It does not, on its own, diagnose ABPA. The next steps are typically a chest CT looking for bronchiectasis or mucus plugs, total IgE measurement, Aspergillus-specific IgG, blood eosinophil count, and ideally a referral to a pulmonologist or specialist allergist familiar with ABPA.

If your total IgE is very high (often above 500 to 1000 IU/mL) and Asp f 6 and Asp f 4 are positive, the diagnostic picture for ABPA becomes strong. If only Asp f 6 is positive and you have eczema, broad mold cross-reactivity is a likely explanation and ABPA becomes less probable. Either way, the result is a starting point for a specialist workup, not a verdict you should interpret alone.

How It Compares to More Common Tests

Whole-extract Aspergillus fumigatus IgE catches almost everyone who is sensitized (sensitivity around 99 to 100%), but it cannot distinguish someone who is merely reacting to mold spores from someone whose immune system is actively damaging their airways. Total IgE rises in many allergic and parasitic conditions and lacks specificity. Asp f 6 IgE answers a narrower but more useful question: is your fungal allergy the type that is more often associated with ABPA?

Source: Luo et al. 2020; Hemmann et al. 1999; Casaulta et al. 2005; Muthu et al. 2018.

What this means for you: a positive Asp f 6 result carries more weight toward an ABPA diagnosis than a positive whole-extract Aspergillus test, but it should always be interpreted in the context of other markers and your symptoms.